Kala Pharmaceuticals Cash Conversion Cycle 2011-2026 | KALA

Annual Cash Conversion Cycle Kala Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	720	405	969	1.17 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.17 K	405	817

Quarterly Cash Conversion Cycle Kala Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	1.52 K	583	943	-	364	360	305	392	395	1.05 K	902	894	727	513	528	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.52 K	305	677

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Verastem VSTM	38.5	$ 5.04	-4.73 %	$ 349 M	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	-54.4	-	-	$ 546 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Avid Bioservices CDMO	85.5	-	-	$ 789 M	USA
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	72.3	$ 12.41	-11.1 %	$ 1.88 B	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
BioDelivery Sciences International BDSI	340	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	-193	$ 1.05	-3.67 %	$ 21.5 M	Israel
Summit Therapeutics SMMT	379	$ 16.58	-3.94 %	$ 12.4 B	Britain
Zymeworks ZYME	211	$ 24.18	-2.07 %	$ 1.25 B	Canada
AbbVie ABBV	284	$ 209.4	-0.83 %	$ 370 B	USA
AbCellera Biologics ABCL	173	$ 3.27	-2.39 %	$ 977 M	Canada
Altimmune ALT	7.85 K	$ 3.02	-5.63 %	$ 266 M	USA
Alnylam Pharmaceuticals ALNY	46.6	$ 317.36	-3.29 %	$ 41.6 B	USA
Aytu BioScience AYTU	174	$ 2.6	-2.8 %	$ 16.3 M	USA
Arbutus Biopharma Corporation ABUS	50	$ 4.29	-3.6 %	$ 822 M	Canada